Cost-effectiveness of a randomized controlled trial comparing low-dose aspirin to placebo for the prevention of recurrent preterm birth

Cost-effectiveness of a randomized controlled trial comparing low-dose aspirin to placebo for the prevention of recurrent preterm birth

To assess the cost-effectiveness of low-dose aspirin compared to placebo for the prevention of recurrent preterm birth from a healthcare perspective. This was a cost-effectiveness analysis alongside a multicenter, randomized, double-blinded, placebo-controlled trial. We included women with a singlet...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of gynecology and obstetrics 2024-11
Hauptverfasser: Landman, Anadeijda J E M C, Broulikova, Hana M, Visser, Laura, Nijman, Tobias A J, Hemels, Marieke A C, Vollebregt, Karin C, Boormans, Elisabeth M A, Bremer, Henk A, Tuinman, Esther, Langenveld, Josje, van der Made, Flip, Rijnders, Robbert J P, van Vliet, Huib A A M, Freeman, Liv M, de Heus, Roel, Blaauw, Judith, Krabbendam, Ineke, van de Laar, Rafli, Verberg, Marieke F G, Scheepers, Hubertina C J, Mol, Ben W, de Groot, Christianne J M, Oudijk, Martijn A, Bosmans, Judith E, de Boer, Marjon A
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To assess the cost-effectiveness of low-dose aspirin compared to placebo for the prevention of recurrent preterm birth from a healthcare perspective. This was a cost-effectiveness analysis alongside a multicenter, randomized, double-blinded, placebo-controlled trial. We included women with a singleton pregnancy and a previous spontaneous preterm birth
ISSN:1879-3479
1879-3479
DOI:10.1002/ijgo.16024